The purpose of this public workshop is to provide stakeholders a forum for discussion of data needs and to obtain feedback on possible modeling scenarios to explore emergency supply situations should a pandemic or epidemic disease or other events that could adversely impact the blood supply in the United States occur.
The public workshop will include presentations and panel discussions with experts from academia, regulated industry, government, and other stakeholders.
Date and Time: The public workshop will be held on July 24, 2012, from 8:30 a.m. to 5 p.m.
Location: The public workshop will be held at the Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Ave, Bethesda, MD 20814, 301-657-1234.
Contact Person: Mark Walderhaug, Center for Biologics Evaluation and Research (HFM-210), Food and Drug Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852-1448, 301-827-6028, email: Mark.Walderhaug@fda.hhs.gov.
Registration: Visit http://fda.contractmeetings.com to register or mail/email your registration information (including name, title, firm name, address, telephone, and fax numbers) to Mark Walderhaug (see Contact Person) by July 17, 2012. There is no registration fee for the public workshop. Early registration is recommended because seating is limited. Registration on the day of the public workshop will be provided on a space available basis beginning at 8 a.m.
If you need special accommodations due to a disability, please contact Mark Walderhaug (see Contact Person) at least 7 days in advance.